What are the common genetic mutations associated with leiomyosarcoma, and how do they influence treatment decisions?
No direct evidence specifically links genetic mutations in leiomyosarcoma with tailored treatment decisions. However, mutations in BRCA1/2, ATRX, and TP53 may guide use of targeted therapies, emphasizing the role of comprehensive molecular profiling in management.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-28
- DOI
- https://doi.org/10.5281/zenodo.23736597
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00